HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xuemei Zhang Selected Research

histidylhistidine (His-His)

4/2012Cigarette smoking strongly modifies the association of complement factor H variant and the risk of lung cancer.
9/2010Functional evaluation of missense variations in the human MAD1L1 and MAD2L1 genes and their impact on susceptibility to lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xuemei Zhang Research Topics

Disease

94Neoplasms (Cancer)
01/2022 - 06/2003
35Infections
02/2022 - 07/2005
29Inflammation (Inflammations)
11/2022 - 08/2009
29Pneumococcal Infections
01/2022 - 06/2007
22Carcinogenesis
01/2021 - 08/2005
19Lung Neoplasms (Lung Cancer)
06/2021 - 06/2003
13Neoplasm Metastasis (Metastasis)
01/2022 - 12/2006
12Asthma (Bronchial Asthma)
11/2022 - 06/2003
11Breast Neoplasms (Breast Cancer)
10/2021 - 01/2012
10Sepsis (Septicemia)
01/2022 - 01/2008
9Fibrosis (Cirrhosis)
01/2022 - 01/2016
9Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 06/2007
9Pneumonia (Pneumonitis)
01/2022 - 03/2010
9Stomach Neoplasms (Stomach Cancer)
01/2022 - 06/2006
9Carcinoma (Carcinomatosis)
12/2018 - 01/2004
9Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2018 - 07/2010
8Necrosis
08/2021 - 03/2008
7Brain Ischemia (Cerebral Ischemia)
01/2022 - 08/2010
7Colonic Neoplasms (Colon Cancer)
06/2021 - 01/2014
6Acute Lung Injury
03/2020 - 12/2009
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2019 - 07/2011
6Insulin Resistance
01/2016 - 06/2009
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2016 - 05/2008
5Hepatocellular Carcinoma (Hepatoma)
01/2022 - 05/2017
5Osteoporosis
10/2021 - 09/2010
5Esophageal Neoplasms (Esophageal Cancer)
07/2021 - 08/2005
5Human Influenza (Influenza)
01/2021 - 01/2014
5Shock
01/2021 - 01/2008
5Stroke (Strokes)
01/2020 - 01/2011
5Body Weight (Weight, Body)
02/2018 - 03/2011
5Infarction (Infarctions)
01/2018 - 07/2010
5Esophageal Squamous Cell Carcinoma
01/2018 - 08/2005
4Rheumatoid Arthritis
02/2022 - 11/2018
4Diarrhea
01/2022 - 01/2021
4Cardiovascular Diseases (Cardiovascular Disease)
10/2021 - 01/2018
4Hemorrhage
05/2021 - 05/2015
4Congenital Heart Defects (Congenital Heart Defect)
01/2021 - 08/2010
4Glioma (Gliomas)
11/2020 - 01/2017
4Diabetic Nephropathies (Diabetic Nephropathy)
01/2017 - 01/2016
4Hypertension (High Blood Pressure)
05/2014 - 08/2008
4Ovarian Neoplasms (Ovarian Cancer)
02/2013 - 05/2009
3Toxoplasmosis
02/2022 - 03/2020
3Heart Arrest (Cardiac Arrest)
01/2022 - 01/2021
3Chronic Renal Insufficiency
01/2022 - 03/2017
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 05/2008

Drug/Important Bio-Agent (IBA)

55Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2008
24CytokinesIBA
01/2022 - 01/2008
17MicroRNAs (MicroRNA)IBA
01/2019 - 01/2012
14Pharmaceutical PreparationsIBA
02/2022 - 07/2008
12VaccinesIBA
09/2021 - 05/2009
11Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2008
10Interleukin-6 (Interleukin 6)IBA
01/2022 - 07/2009
10LigandsIBA
01/2022 - 07/2004
10Messenger RNA (mRNA)IBA
01/2022 - 07/2013
10ORALIT (ORS)IBA
01/2022 - 12/2006
9Streptococcus pneumoniae plY proteinIBA
01/2022 - 03/2010
9AntigensIBA
02/2018 - 05/2007
8Therapeutic UsesIBA
01/2022 - 01/2016
8Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2009
8EnzymesIBA
10/2021 - 03/2007
8DNA (Deoxyribonucleic Acid)IBA
01/2020 - 06/2003
7Polysaccharides (Glycans)IBA
02/2022 - 03/2010
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 07/2009
7AntibodiesIBA
01/2020 - 06/2007
7LipopolysaccharidesIBA
10/2018 - 01/2008
7Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2011 - 08/2005
6Biological ProductsIBA
02/2022 - 01/2008
6Complement System Proteins (Complement)IBA
01/2022 - 04/2012
6Peptides (Polypeptides)IBA
01/2022 - 03/2014
6Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 07/2005
6LipidsIBA
10/2017 - 01/2003
5Neuroprotective AgentsIBA
01/2022 - 08/2010
5Toll-Like Receptor 4IBA
01/2022 - 04/2014
5Interleukin-27 (Interleukin 27)IBA
10/2021 - 04/2013
5ProgranulinsIBA
01/2020 - 06/2015
5AntioxidantsIBA
02/2019 - 08/2011
5Ethanol (Ethyl Alcohol)IBA
12/2018 - 01/2014
5Interleukin-17 (Interleukin 17)IBA
12/2017 - 01/2014
4Folic Acid (Vitamin M)FDA LinkGeneric
01/2022 - 08/2005
4Long Noncoding RNAIBA
01/2022 - 01/2019
4Matrix Metalloproteinases (MMPs)IBA
01/2022 - 12/2006
4Interleukin-10 (Interleukin 10)IBA
04/2021 - 07/2009
4Interleukin-4 (Interleukin 4)IBA
01/2021 - 05/2015
4Carrier Proteins (Binding Protein)IBA
01/2021 - 05/2009
4taraxasterolIBA
12/2019 - 07/2013
4InterferonsIBA
12/2019 - 05/2017
4oxidized low density lipoproteinIBA
10/2017 - 04/2003
4AzoxymethaneIBA
01/2017 - 07/2013
4Virulence Factors (Pathogenicity Factors)IBA
01/2017 - 06/2012
4Phosphotransferases (Kinase)IBA
07/2013 - 08/2009
4Peptide Hydrolases (Proteases)FDA Link
06/2012 - 11/2008
3InflammasomesIBA
11/2022 - 04/2021
3OvalbuminIBA
11/2022 - 07/2013
3CollagenIBA
01/2022 - 09/2020
3Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022 - 01/2020

Therapy/Procedure

33Therapeutics
11/2022 - 08/2008
4Length of Stay
01/2022 - 06/2003
3Resuscitation
01/2022 - 01/2021
3Immunotherapy
01/2022 - 12/2020
3Radiotherapy
01/2022 - 01/2021